IMED Poland Sp. z o.o. won Poland – Various medicinal products – Dostawa produktu leczniczego Mifamurtide do niekomercyjnego badania klinicznego (DRAGONFLY) from Instytut Matki i Dziecka

Instytut Matki i Dziecka · Poland government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$274.1M
Award Value
March 10, 2026
Award Date
Awarded
Status

Award Overview

IMED Poland Sp. z o.o. was awarded Poland – Various medicinal products – Dostawa produktu leczniczego Mifamurtide do niekomercyjnego badania klinicznego (DRAGONFLY) by Instytut Matki i Dziecka in Poland, tracked by GlobalGov. The award is valued at $274.1M. It was awarded on March 10, 2026. Classification: NAICS 33690000. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeIMED Poland Sp. z o.o.
Awardee countryPoland
Awarding agencyInstytut Matki i Dziecka
CountryPoland
Award value$274.1M
Award dateMarch 10, 2026
NAICS33690000
Official sourceView original award record
Last verifiedSeptember 1, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Track every Poland contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required